105 related articles for article (PubMed ID: 2526260)
1. [Antimycoplasmal activities of ofloxacin and commonly used antimicrobial agents on Mycoplasma gallisepticum].
Takahashi I; Yoshida T
Jpn J Antibiot; 1989 May; 42(5):1166-72. PubMed ID: 2526260
[TBL] [Abstract][Full Text] [Related]
2. [Susceptibilities of Escherichia coli, Salmonella and Staphylococcus aureus isolated from animals to ofloxacin and commonly used antimicrobial agents].
Takahashi I; Yoshida T; Higashide Y; Sakano T
Jpn J Antibiot; 1990 Jan; 43(1):89-99. PubMed ID: 2190017
[TBL] [Abstract][Full Text] [Related]
3. [In vitro resistance acquisition in Mycoplasma gallisepticum against ofloxacin, tylosin and spectinomycin].
Takahashi I; Yoshida T; Higashide Y; Sawada T
Jpn J Antibiot; 2002 Jun; 55(3):291-301. PubMed ID: 12199113
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of Mycoplasma hyosynoviae and M. hyorhinis to antimicrobial agents.
Kobayashi H; Sonmez N; Morozumi T; Mitani K; Ito N; Shiono H; Yamamoto K
J Vet Med Sci; 1996 Nov; 58(11):1107-11. PubMed ID: 8959659
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against recent field isolates of Mycoplasma bovis.
Ayling RD; Baker SE; Peek ML; Simon AJ; Nicholas RA
Vet Rec; 2000 Jun; 146(26):745-7. PubMed ID: 10909906
[TBL] [Abstract][Full Text] [Related]
6. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). I. Susceptibility distribution].
Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1989 Oct; 42(10):2141-73. PubMed ID: 2691714
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of sparfloxacin against mycoplasmas].
Renaudin H; Bebear C
Pathol Biol (Paris); 1992 May; 40(5):450-4. PubMed ID: 1323094
[TBL] [Abstract][Full Text] [Related]
8. [In vitro antimycobacterial activity of a new quinolone, NM394].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
[TBL] [Abstract][Full Text] [Related]
9. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
[TBL] [Abstract][Full Text] [Related]
10. [Antibacterial activities of ofloxacin against recent isolates from patients with community-acquired infections].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1991 Sep; 44(9):941-57. PubMed ID: 1960856
[TBL] [Abstract][Full Text] [Related]
11. Antimycoplasmal activities of (S)-(-)-9-fluoro-2,3-dihydro-3-methyl-10 -[4-(2-pyridyl)-1-piperazinyl]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine -6-carboxylic acid (YH-6) in comparison with other antibiotics in vitro.
Ye H; Wu JM; Yang YS; Ji RY; Chen KX
Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):1031-4. PubMed ID: 11270970
[TBL] [Abstract][Full Text] [Related]
12. The effects of tetracycline, minocycline, doxycycline and ofloxacin on Prevotella intermedia biofilm.
Takahashi N; Ishihara K; Kimizuka R; Okuda K; Kato T
Oral Microbiol Immunol; 2006 Dec; 21(6):366-71. PubMed ID: 17064394
[TBL] [Abstract][Full Text] [Related]
13. In vitro comparison of the activity of various antibiotics and drugs against new Taiwan isolates and standard strains of avian mycoplasma.
Lin MY
Avian Dis; 1987; 31(4):705-12. PubMed ID: 3442523
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of Ureaplasma urealyticum clinical isolates to new macrolides.
Kanamoto Y; Miyake Y; Suginaka H; Usui T
Chemotherapy; 1991; 37(4):256-9. PubMed ID: 1790724
[TBL] [Abstract][Full Text] [Related]
15. [Antimicrobial activity of ofloxacin against recent clinical isolates from otitis media and otitis externa].
Matsumoto Y; Suzuki Y; Ishii Y; Ishihara R; Nakazawa A; Nakane Y; Nishinari C; Deguchi K
Jpn J Antibiot; 1998 Sep; 51(9):561-75. PubMed ID: 9846283
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). I. Susceptibility distribution].
Kosakai N; Kumamoto Y; Sakai S; Hirose T; Okayama S; Shigeta S; Shiraiwa Y; Yoshida H; Miura Y; Ogata M
Jpn J Antibiot; 1987 Dec; 40(12):1975-2011. PubMed ID: 3448255
[TBL] [Abstract][Full Text] [Related]
17. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo comparisons of valnemulin, tiamulin, tylosin, enrofloxacin, and lincomycin/spectinomycin against Mycoplasma gallisepticum.
Jordan FT; Forrester CA; Ripley PH; Burch DG
Avian Dis; 1998; 42(4):738-45. PubMed ID: 9876842
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.
Sanson-Le Pors MJ; Casin IM; Thebault MC; Arlet G; Perol Y
Antimicrob Agents Chemother; 1986 Sep; 30(3):512-3. PubMed ID: 2946262
[TBL] [Abstract][Full Text] [Related]
20. [Antibacterial activities of ofloxacin against recent clinical isolates from patients with ocular infections].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1993 May; 46(5):349-63. PubMed ID: 8326675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
